Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesEndocrine, Nutritional and Metabolic Diseases and DisordersDRG 645-endocrine-disorders-without-cc-mcc
    Ask Trek AI about this page

    Endocrine Disorders without CC/MCC: Inpatient Reimbursement Overview

    DRG 645 addresses inpatient admissions for endocrine disorders without Complication or Comorbidity or Major Complication or Comorbidity, encompassing diagnoses like uncomplicated diabetes, thyroid, and adrenal conditions that do not require additional complex care. This grouping matters for inpatient reimbursement because it defines a lower resource-intensity category that influences Centers for Medicare & Medicaid Services payment rates and hospital case-mix metrics.

    Customize your policy alerts

    Sign up for drg 645 policy alerts

    Get alerted when payer policies referencing 645 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 645 Overview

    DRG 645 covers inpatient admissions for endocrine disorders without a Complication or Comorbidity or Major Complication or Comorbidity, including primary diagnoses such as uncontrolled diabetes without additional systemic complications, thyroid disorders, and adrenal or pituitary conditions managed during a single hospital stay. This Diagnosis-Related Group groups cases with relatively lower expected resource use compared with endocrine cases that include complications, which affects relative payment under Medicare inpatient prospective payment systems. The classification impacts hospital reimbursement, length-of-stay expectations, and case-mix reporting for Centers for Medicare & Medicaid Services payment determinations.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute endocrinology intervention trials: randomized or prospective studies testing short-term inpatient interventions for acute metabolic decompensations (for example, protocols for faster correction of severe hyperglycemia, thyroid storm stabilization pathways, or adrenal crisis management bundles). These studies enroll patients admitted with acute endocrine emergencies or severe exacerbations of chronic endocrine disease, comparing different timing, monitoring strategies, or supportive therapies to reduce time to biochemical control and length of stay. Results inform hospital protocols and utilization management by identifying interventions that safely shorten admissions or reduce complication rates, which affects resource use and payer costs.
    • Comparative effectiveness studies for inpatient management strategies: pragmatic trials or observational comparative-effectiveness research evaluating different in-hospital care models or therapeutic algorithms for common noncritical endocrine diagnoses (for example, medication choice and titration strategies for hospitalized patients with poorly controlled diabetes, or pathways for new-onset hypothyroidism identified during admission). These studies focus on typical adult inpatient populations without major complications (the DRG without CC/MCC), assessing outcomes such as glycemic excursions, readmission rates, and discharge medication accuracy. Findings help clinicians and payers determine which standard-of-care approaches produce better short-term outcomes and lower downstream utilization across diverse hospital settings.
    • Post-discharge outcomes and transitions-of-care research: cohort studies and implementation research examining discharge planning, outpatient follow-up, and care coordination for patients admitted for endocrine disorders without complications — for example, interventions to improve outpatient endocrinology follow-up, medication reconciliation, education on self-management, and remote monitoring after discharge. These studies target the transition period to reduce early readmissions, emergency visits, and medication-related errors among patients who are clinically stable at discharge. Insights are relevant to providers and payers because effective transition interventions can reduce avoidable resource use and improve long-term disease control, impacting readmission metrics and overall cost of care.

    Related Codes

    614-ADRENAL-AND-PITUITARY-PROCEDURES-WITH-CC-MCC

    Adrenal and Pituitary Procedures with CC/MCC: Inpatient Reimbursement Overview

    615-ADRENAL-AND-PITUITARY-PROCEDURES-WITHOUT-CC-MCC

    Adrenal and Pituitary Procedures without CC/MCC: Inpatient Reimbursement Overview

    616-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    617-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    618-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    619-O-R-PROCEDURES-FOR-OBESITY-WITH-MCC

    O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

    620-O-R-PROCEDURES-FOR-OBESITY-WITH-CC

    O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

    621-O-R-PROCEDURES-FOR-OBESITY-WITHOUT-CC-MCC

    O.R. Procedures for Obesity without CC/MCC: Inpatient Reimbursement Overview

    622-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    623-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 25

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.